Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sruthi S Nair & Saiju Jacob. (2023) Novel Immunotherapies for Myasthenia Gravis. ImmunoTargets and Therapy 12, pages 25-45.
Read now
Read now
Akiyuki Uzawa & Kimiaki Utsugisawa. (2023) Biological therapies for myasthenia gravis. Expert Opinion on Biological Therapy 23:3, pages 253-260.
Read now
Read now
Huan Li, Juanjuan Chen, Yuanhui Hu, Xin Cai, Dongling Tang & Pingan Zhang. (2021) Serum C1q Levels Have Prognostic Value for Sepsis and are Related to the Severity of Sepsis and Organ Damage. Journal of Inflammation Research 14, pages 4589-4600.
Read now
Read now
Articles from other publishers (22)
Xin Chen, Jiayi Qiu, Zihui Gao, Boya Liu, Chen Zhang, Weiran Yu, Jiawen Yang, Yuntian Shen, Lei Qi, Xinlei Yao, Hualin Sun & Xiaoming Yang. (2023) Myasthenia gravis: Molecular mechanisms and promising therapeutic strategies. Biochemical Pharmacology 218, pages 115872.
Crossref
Crossref
Yukiko Ozawa, Akiyuki Uzawa, Yosuke Onishi, Manato Yasuda, Yuta Kojima & Satoshi Kuwabara. (2023) Activation of the classical complement pathway in myasthenia gravis with acetylcholine receptor antibodies. Muscle & Nerve 68:5, pages 798-804.
Crossref
Crossref
Kimiaki Utsugisawa, Kazushi Deguchi, Shingo Konno, Masayuki Masuda, Naoya Minami, Hiroyuki Murai, Shigeaki Suzuki, Yasushi Suzuki, Akira Tsujino, Akiyuki Uzawa, Babak Boroojerdi, Guillemette de la Borderie, Melissa Brock, Petra W. Duda, Mark Vanderkelen & James F. HowardJrJr. (2023)
Efficacy and safety of zilucoplan in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the phase III randomized
RAISE
study
. Clinical and Experimental Neuroimmunology.
Crossref
Crossref
Guo-Qing Tang, Yalan Tang, Ketki Dhamnaskar, Michelle D. Hoarty, Rohit Vyasamneni, Douangsone D. Vadysirisack, Zhong Ma, Nanqun Zhu, Jian-Guo Wang, Charlie Bu, Bestine Cong, Elizabeth Palmer, Petra W. Duda, Camil Sayegh & Alonso Ricardo. (2023) Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation. Frontiers in Immunology 14.
Crossref
Crossref
Lia Costa, Emília Sousa & Carla Fernandes. (2023) Cyclic Peptides in Pipeline: What Future for These Great Molecules?. Pharmaceuticals 16:7, pages 996.
Crossref
Crossref
Matthew C. Fleming, Matthew M. Bowler, Rodney Park, Konstantin I. Popov & Albert A. Bowers. (2023) Tyrosinase-Catalyzed Peptide Macrocyclization for mRNA Display. Journal of the American Chemical Society 145:19, pages 10445-10450.
Crossref
Crossref
James F HowardJrJr, Saskia Bresch, Angela Genge, Channa Hewamadduma, John Hinton, Yessar Hussain, Raul Juntas-Morales, Henry J Kaminski, Angelina Maniaol, Renato Mantegazza, Masayuki Masuda, Kumaraswamy Sivakumar, Marek Śmiłowski, Kimiaki Utsugisawa, Tuan Vu, Michael D Weiss, Małgorzata Zajda, Babak Boroojerdi, Melissa Brock, Guillemette de la Borderie, Petra W Duda, Romana Lowcock, Mark Vanderkelen, M Isabel Leite, Dylan Sembinelli, Jeanne Teitelbaum, Michael Nicolle, Emilien Bernard, Juliette Svahn, Marco Spinazzi, Tanya Stojkovic, Sophie Demeret, Nicolas Weiss, Loïc Le Guennec, Sihame Messai, Christine Tranchant, Aleksandra Nadaj-Pakleza, Jean-Baptiste Chanson, Muhtadi Suliman, Leila Zaidi, Celine Tard, Peggy Lecointe, Jana Zschüntzsch, Jens Schmidt, Stefanie Glaubitz, Rachel Zeng, Matthias Scholl, Markus Kowarik, Ulf Ziemann, Markus Krumbholz, Pascal Martin, Christoph Ruschil, Jutta Dünschede, Roswitha Kemmner, Natalie Rumpel, Benjamin Berger, Andreas Totzeck, Tim Hagenacker, Benjamin Stolte, Raffaele Iorio, Amelia Evoli, Silvia Falso, Carlo Antozzi, Rita Frangiamore, Fiammetta Vanoli, Elena Rinaldi, Kazushi Deguchi, Naoya Minami, Yuriko Nagane, Yasushi Suzuki, Sayaka Ishida, Shigeaki Suzuki, Jin Nakahara, Astushi Nagaoka, Shunsuke Yoshimura, Shingo Konno, Youko Tsuya, Akiyuki Uzawa, Tomoya Kubota, Masanori Takahashi, Tatsusada Okuno, Hiroyuki Murai, Nils Erik Gilhus, Marion Boldingh, Tone Hakvåg Rønning, Urszula Chyrchel-Paszkiewicz, Klaudiusz Kumor, Tomasz Zielinski, Krzysztof Banaszkiewicz, Michał Błaż, Agata Kłósek, Mariola Świderek-Matysiak, Andrzej Szczudlik, Aneta Paśko, Lech Szczechowski, Marta Banach, Jan Ilkowski, Solange Kapetanovic Garcia, Patricia Ortiz Bagan, Ana Belén Cánovas Segura, Joana Turon Sans, Nuria Vidal Fernandez, Elena Cortes Vicente, Patricia Rodrigo Armenteros, Mohammad Ashraghi, Ana Cavey, Liam Haslam, Anna Emery, Kore Liow, Sharon Yegiaian, Alexandru Barboi, Rosa Maria Vazquez, Joshua Lennon, Robert M Pascuzzi, Cynthia Bodkin, Sandra Guingrich, Adam Comer, Mark Bromberg, Teresa Janecki, Sami Saba, Marco Tellez, Bakri Elsheikh, Miriam Freimer, Sarah Heintzman, Raghav Govindarajan, Jeffrey Guptill, Janice M Massey, Vern Juel, Natalia Gonzalez, Ali A Habib, Tahseen Mozaffar, Manisha Korb, Namita Goyal, Hannah Machemehl, Georgios Manousakis, Jeffrey Allen, Emily Harper, Constantine Farmakidis, Lilli Saavedra, Mazen Dimachkie, Mamatha Pasnoor, Salma Akhter, Said Beydoun, Courtney McIlduff, Joan Nye, Bhaskar Roy, Bailey Munro Sheldon, Richard Nowak, Benjamin Barnes, Michael Rivner, Niraja Suresh, Jessica Shaw, Brittany Harvey, Lucy Lam, Nikki Thomas, Manisha Chopra, Rebecca E Traub, Sarah Jones, Mary Wagoner, Sejla Smajic, Radwa Aly, Jonathan Katz, Henry Chen, Robert G Miller, Liberty Jenkins, Shaida Khan, Bhupendra Khatri, Lisa Sershon, Pantelis Pavlakis, Shara Holzberg, Yuebing Li, Irys B Caristo, Robert Marquardt, Debbie Hastings, Jacob Rube, Robert P Lisak, Aparna Choudhury, Katherine Ruzhansky, Amit Sachdev, Susan Shin, Joan Bratton, Mary Fetter, Naya McKinnon, Jonathan McKinnon, Laura Sissons-Ross, Amos Sahu & B Jane Distad. (2023) Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study. The Lancet Neurology 22:5, pages 395-406.
Crossref
Crossref
Yoshikazu Kuboi, Yuta Suzuki, Sotaro Motoi, Chiyuki Matsui, Naoki Toritsuka, Tomoya Nakatani, Kazuhiro Tahara, Yoshinori Takahashi, Yoko Ida, Ayaka Tomimatsu, Motohiro Soejima & Toshio Imai. (2023) Identification of potent siRNA targeting complement C5 and its robust activity in pre-clinical models of myasthenia gravis and collagen-induced arthritis. Molecular Therapy - Nucleic Acids 31, pages 339-351.
Crossref
Crossref
Andrew L Mammen, Anthony A Amato, Mazen M Dimachkie, Hector Chinoy, Yessar Hussain, James B Lilleker, Iago Pinal-Fernandez, Yves Allenbach, Babak Boroojerdi, Mark Vanderkelen, Eumorphia Maria Delicha, Harold Koendgen, Ramin Farzaneh-Far, Petra W Duda, Camil Sayegh, Olivier Benveniste, Anthony A. Amato, Olivier Benveniste, Suur Biliciler, Hector Chinoy, Mazen M. Dimachkie, Christyn Edmundson, Miriam Freimer, Anthony Geraci, Yessar Hussain, Pedro Machado, Andrew L. Mammen, Tahseen Mozaffar, Payam Soltanzadeh, Niraja Suresh, Anneke van der Kooi, Yves Allenbach, Matthew Appleby, Richard J Barohn, Nicolas Champtiaux, Christopher Doughty, Jerrica Farias, Constantine Farmakidis, Ali A. Habib, Chafic Karam, James Lilleker, Samantha Lorusso, Mamatha Pasnoor, Iago Pinal-Fernandez, Giorgia Querin, Joost Raaphorst, George Ransley, Sami Saba, Kazim Sheikh, Andrew Snedden, Jeffrey Statland & Tuan Vu. (2023) Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial. The Lancet Rheumatology 5:2, pages e67-e76.
Crossref
Crossref
Vidya Sadanand Limaye. (2023) Preventing myofibre necrosis in immune-mediated necrotising myopathy—is complement inhibition effective?. The Lancet Rheumatology 5:2, pages e60-e61.
Crossref
Crossref
Peter Kurtzhals, Søren Østergaard, Erica Nishimura & Thomas Kjeldsen. (2022) Derivatization with fatty acids in peptide and protein drug discovery. Nature Reviews Drug Discovery 22:1, pages 59-80.
Crossref
Crossref
Yangqiang Chen, Chonggang Duan, Kai Chen, Shumeng Sun, Daizhou Zhang & Xiangjing Meng. (2022) Screening technology of cyclic peptide library based on gene encoding. Medicine in Drug Discovery 16, pages 100145.
Crossref
Crossref
Daichi Koiwa, Masayuki Ohira, Takahiro Hiramatsu, Hidenori Abe, Tetsuji Kawamoto, Yuji Ishihara, Bernardo Ignacio, Noel Mansour & Todd Romoff. (2022) Rapid and efficient syntheses of tryptophans using a continuous-flow quaternization–substitution reaction of gramines with a chiral nucleophilic glycine equivalent. Organic & Biomolecular Chemistry 20:42, pages 8331-8340.
Crossref
Crossref
Christina Helmling & Christian N. Cunningham. 2022. Approaching the Next Inflection in Peptide Therapeutics: Attaining Cell Permeability and Oral Bioavailability. Approaching the Next Inflection in Peptide Therapeutics: Attaining Cell Permeability and Oral Bioavailability
27
53
.
RUTH Fernandez-Ruiz & Howard MICHAEL Belmont. (2022) The role of anticomplement therapy in lupus nephritis. Translational Research 245, pages 1-17.
Crossref
Crossref
Deepak Menon & Vera Bril. (2022) Pharmacotherapy of Generalized Myasthenia Gravis with Special Emphasis on Newer Biologicals. Drugs 82:8, pages 865-887.
Crossref
Crossref
Jaap J. Plomp, Maartje G.M. Huijbers, Jan J.G.M. Verschuuren & Anna Borodovsky. (2022) A bioassay for neuromuscular junction-restricted complement activation by myasthenia gravis acetylcholine receptor antibodies. Journal of Neuroscience Methods 373, pages 109551.
Crossref
Crossref
Jan JGM Verschuuren, Jacqueline Palace, Hiroyuki Murai, Martijn R Tannemaat, Henry J Kaminski & Vera Bril. (2022) Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders. The Lancet Neurology 21:2, pages 189-202.
Crossref
Crossref
Ankita Wal, Pranay Wal, Ashutosh Pandey, Himangi Vig, Akash Ved & Himanshu Bhusan Samal. (2022) Overview of Myasthenia Gravis Subgroups and its influence on Pregnancy and their Treatment Advances. Pharmacophore 13:3, pages 19-30.
Crossref
Crossref
Evelyn Jou-Chen Huang, Meng-Huang Wu, Tsung-Jen Wang, Tsung-Jen Huang, Yan-Rong Li & Ching-Yu Lee. (2022) Myasthenia Gravis: Novel Findings and Perspectives on Traditional to Regenerative Therapeutic Interventions. Aging and disease, pages 0.
Crossref
Crossref
Ilaria Chiapparoli, Claudio Galluzzo, Carlo Salvarani & Nicolò Pipitone. (2022) A glance into the future of myositis therapy. Therapeutic Advances in Musculoskeletal Disease 14, pages 1759720X2211002.
Crossref
Crossref
Hai Xiao, Ka Wu, Xiaoliu Liang, Rong Li & Keng Po Lai. (2021) Clinical Efficacy and Safety of Eculizumab for Treating Myasthenia Gravis. Frontiers in Immunology 12.
Crossref
Crossref